Wogonin induced cytotoxicity in human hepatocellular carcinoma cells by activation of unfolded protein response and inactivation of AKT

Hepatology Research

Volumn 43, Issue 8, 2013, Pages 890-905

  Xu, Min ^a   Lu, Na ^a   Zhang, Haiwei ^a   Dai, Qinsheng ^a   Wei, Libin ^a   Li, Zhiyu ^b   You, Qidong ^b   Guo, Qinglong ^a  

^a China Pharmaceutical University   (China)

^b CHINA PHARMACEUTICAL UNIVERSITY   (China)

Author keywords

AKT; Cytotoxicity; H2O2; Hepatocellular carcinoma; Unfolded protein response; Wogonin

Indexed keywords

CALCIUM; HYDROGEN PEROXIDE; MESSENGER RNA; PROTEIN KINASE B; WOGONIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; BODY WEIGHT; CALCIUM TRANSPORT; CARCINOGENICITY; CARCINOMA CELL; CELL DEATH; CELL STRAIN HEPG2; CELL VIABILITY; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; CYTOTOXICITY TEST; ENDOPLASMIC RETICULUM; ENZYME INACTIVATION; GENE EXPRESSION; HUMAN; HUMAN CELL; LIVER CELL CARCINOMA; MOUSE; NEOPLASM; NITROBLUE TETRAZOLIUM TEST; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; TUMOR VOLUME; TUMOR XENOGRAFT; UNFOLDED PROTEIN RESPONSE; WEIGHT; WESTERN BLOTTING;

EID: 84882586115     PISSN: 13866346     EISSN: 1872034X     Source Type: Journal    
DOI: 10.1111/hepr.12036     Document Type: Article

References (64)

1. Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D. Global cancer statistics. CA Cancer J Clin 2011; 61: 69-90.
2. El-Serag HB. Hepatocellular carcinoma. N Engl J Med 2011; 365: 1118-1127.
3. Bruix J, Llovet JM. Major achievements in hepatocellular carcinoma. Lancet 2009; 373: 614-616.
4. Whittaker S, Marais R, Zhu AX. The role of signaling pathways in the development and treatment of hepatocellular carcinoma. Oncogene 2010; 29: 4989-5005.
5. Llovet JM, Burroughs A, Bruix J. Hepatocellular carcinoma. Lancet 2003; 362: 1907-1917.
6. Aravalli RN, Steer CJ, Cressman ENK. Molecular mechanisms of hepatocellular carcinoma. Hepatology 2008; 48: 2047-2063.
7. Dara L, Ji C, Kaplowitz N. The contribution of endoplasmic reticulum stress to liver disease. Hepatology 2011; 53: 1752-1763.
8. Malhi H, Kaufman RJ. Endoplasmic reticulum stress in liver disease. J Hepatol 2011; 54: 795-809.
9. Ji C, Kaplowitz N. ER stress: can the liver cope? J Hepatol 2006; 45: 321-333.
10. Xu C, Bailly-Maitre B, Reed JC. Endoplasmic reticulum stress: cell life and death decisions. J Clin Invest 2005; 115: 2656-2664.
11. Ron D, Walter P. Signal integration in the endoplasmic reticulum unfolded protein response. Nat Rev Mol Cell Biol 2007; 8: 519-529.
12. Pfaffenbach KT, Lee AS. The critical role of GRP78 in physiologic and pathologic stress. Curr Opin Cell Biol 2011; 23: 150-156.
13. Moenner M, Pluquet O, Bouchecareilh M, Chevet E. Integrated endoplasmic reticulum stress responses in cancer. Cancer Res 2007; 22: 10631-10634.
14. Lee AS. GRP78 induction in cancer: therapeutic and prognostic implications. Cancer Res 2007; 67: 3496-3499.
15. Shuda M, Kondoh N, Imazeki N etal. Activation of the ATF6, XBP1 and grp78 genes in human hepatocellular carcinoma: a possible involvement of the ER stress pathway in hepatocarcinogenesis. J Hepatol 2003; 38: 605-614.
16. Szegezdi E, Logue SE, Gorman AM, Samali A. Mediators of endoplasmic reticulum stress-induced apoptosis. EMBO Rep 2006; 7: 880-885.
17. Rao RV, Ellerby HM, Bredesen DE. Coupling endoplasmic reticulum stress to the cell death program. Cell Death Differ 2004; 11: 372-380.
18. Marciniak SJ, Yun CY, Oyadomari S etal. CHOP induces death by promoting protein synthesis and oxidation in the stressed endoplasmic reticulum. Genes Dev 2004; 18: 3066-3077.
19. Kim I, Xu W, Reed JC. Cell death and endoplasmic reticulum stress: disease relevance and therapeutic opportunities. Nat Rev Drug Discov 2008; 7: 1013-1030.
20. Schmitz KJ, Wohlschlaeger J, Lang H etal. Activation of the ERK and AKT signalling pathway predicts poor prognosis in hepatocellular carcinoma and ERK activation. J Hepatol 2008; 48: 83-90.
21. Luo J, Manning BD, Cantley LC. Targeting the PI3K-Akt pathway in human cancer: rationale and promise. Cancer Cell 2003; 4: 257-262.
22. Hennessy BT, Smith DL, Ram PT, Lu Y, Mills GB. Exploiting the PI3K/AKT pathway for cancer drug discovery. Nat Rev Drug Discov 2005; 4: 988-1004.
23. Surh YJ. Cancer chemoprevention with dietary phytochemicals. Nat Rev Cancer 2003; 3: 768-780.
24. Li-Weber M. New therapeutic aspects of flavones: the anticancer properties of scutellaria and its main active constituents wogonin, baicalein and baicalin. Cancer Treat Rev 2009; 35: 57-68.
25. Zhang K, Guo QL, You Q etal. Wogonin induces the granulocytic differentiation of human NB4 promyelocytic leukemia cells and upregulates phospholipid scramblase 1 gene expression. Cancer Sci 2008; 99: 689-695.
26. Zhang HW, Yang Y, Zhang K etal. Wogonin induced differentiation and G1 phase arrest of human U-937 leukemia cells via PKCδ phosphorylation. Eur J Pharmacol 2008; 591: 7-12.
27. Yang L, Zhang HW, Hu R etal. Wogonin induces G1 phase arrest through inhibiting Cdk4 and cyclin D1 concomitant with an elevation in p21Cip1 in human cervical carcinoma HeLa cells. Biochem Cell Biol 2009; 87: 933-942.
28. Lee D, Rhee JG, Zhang L. Reactive oxygen species up-regulate p53 and puma; a possible mechanism for apoptosis during combined treatment with TRAIL and wogonin. Br J Pharmacol 2009; 157: 1189-1202.
29. Lee DH, Kim C, Zhang L, Lee YJ. Role of p53, PUMA, and Bax in wogonin-induced apoptosis in human cancer cells. Biochem Pharmacol 2008; 75: 2020-2033.
30. Wang W, Guo Q, You Q etal. Involvement of bax/bcl-2 in wogonin-induced apoptosis of human hepatoma cell line SMMC-7721. Anticancer Drugs 2006; 17: 797-805.
31. Yu JQ, Liu HB, Tian DZ, Liu YW, Lei JC, Zou GL. Changes in mitochondrial membrane potential and reactive oxygen species during wogonin-induced cell death in human hepatoma cells. Hepatol Res 2007; 37: 68-76.
32. Lee E, Enomoto R, Koshiba C, Hirano H. Inhibition of p-glycoprotein by wogonin is involved with the potentiation of etoposide-induced apoptosis in cancer cells. Ann N Y Acad Sci 2009; 1171: 132-136.
33. Lin CC, Shieht DE. In vivo hepatoprotective effect of baicalein, baicalin and wogonin from Scutellaria rivularis. Phytother Res 1996; 10: 651-654.
34. Guo Q, Zhao L, You Q etal. Anti-hepatitis B virus activity of wogonin in vitro and in vivo. Antiviral Res 2007; 74: 16-24.
35. Choa J, Lee HK. Wogonin inhibits excitotoxic and oxidative neuronal damage in primary cultured rat cortical cells. Eur J Pharmacol 2004; 485: 105-110.
36. Chena YC, Shenb SC, Chena LG, Lee TJ, Yang LL. Wogonin, baicalin, and baicalein inhibition of inducible nitric oxide synthase and cyclooxygenase-2 gene expressions induced by nitric oxide synthase inhibitors and lipopolysaccharide. Biochem Pharmacol 2001; 61: 1417-1427.
37. Liu YM, Wang X, Nawaz A etal. Wogonin ameliorates lipotoxicity-induced apoptosis of cultured vascular smooth muscle cells via interfering with DAG-PKC pathway. Acta Pharmacol Sin 2011; 32: 1475-1482.
38. Lin CC, Kuo CL, Lee MH etal. Wogonin triggers apoptosis in human osteosarcoma U-2 OS cells through the endoplasmic reticulum stress, mitochondrial dysfunction and caspase-3-dependent signaling pathways. Int J Oncol 2011; 39: 217-224.
39. Ma Y, Hendershot LM. The role of the unfolded protein response in tumour development: friend or foe? Nat Rev Cancer 2004; 4: 966-977.
40. Xu M, Lu N, Sun ZY etal. Activation of the unfolded protein response contributed to the selective cytotoxicity of oroxylin A in human hepatocellular carcinoma HepG2 cells. Toxicol Lett 2012; 212: 113-125.
41. 2+ overload in malignant hepatoma and normal hepatic cells. J Cell Biochem 2010; 111: 1629-1641.
42. Oyadomari S, Mori M. Roles of CHOP/GADD153 in endoplasmic reticulum stress. Cell Death Differ 2004; 11: 381-389.
43. Zhao Q, Wang J, Zou MJ etal. Wogonin potentiates the antitumor effects of low dose 5-fluorouracil against gastric cancer through induction of apoptosis by down-regulation of NF-kappaB and regulation of its metabolism. Toxicol Lett 2010; 197: 201-210.
44. 2+-dependent apoptosis. Blood 2008; 111: 2354-2363.
45. Fas SC, Baumann S, Zhu JY etal. Wogonin sensitizes resistant malignant cells to TNFα- and TRAIL-induced apoptosis. Blood 2006; 108: 3700-3706.
46. Polier G, Ding J, Konkimalla BV etal. Wogonin and related natural flavones are inhibitors of CDK9 that induce apoptosis in cancer cells by transcriptional suppression of Mcl-1. Cell Death Dis 2011; 2: e182.
47. Chow SE, Chang YL, Chuang SF, Wang JS. Wogonin induced apoptosis in human nasopharyngeal carcinoma cells by targeting GSK-3β and ΔNp63. Cancer Chemother Pharmacol 2011; 68: 835-5.
48. Wang W, Guo Q, You Q etal. The anticancer activities of wogonin in murine sarcoma S180 both in vitro and in vivo. Biol Pharm Bull 2006; 29: 1132-1137.
49. Finkel E. The mitochondrion: is it central to apoptosis? Science 2001; 292: 624-626.
50. Lin JH, Li H, Yasumura D etal. IRE1 signaling affects cell fate during the unfolded protein response. Science 2007; 318: 944-949.
51. Tabas I, Ron D. Integrating the mechanisms of apoptosis induced by endoplasmic reticulum stress. Nat Cell Biol 2011; 13: 184-190.
52. Yoshida H, Matsui T, Hosokawa N, Kaufman RJ, Nagata K, Mori KA. Time-dependent phase shift in the mammalian unfolded protein response. Dev Cell 2003; 4: 265-271.
53. Ohoka N, Yoshii S, Hattori T, Onozaki K, Hayashi H. TRB3, a novel ER stress-inducible gene, is induced via ATF4-CHOP pathway and is involved in cell death. EMBO J 2005; 24: 1243-1255.
54. Wang M, Wey S, Zhang Y, Ye R, Lee AS. Role of the unfolded protein response regulator GRP78/BiP in development, cancer, and neurological disorders. Antioxid Redox Signal 2009; 11: 2307-2316.
55. Yamaguchi H, Wang HG. CHOP is involved in endoplasmic reticulum stress induced apoptosis by enhancing DR5 expression in human carcinoma cells. J Biol Chem 2004; 279: 45495-45502.
56. Örd T, Örd D, Kõivomäg M, Jukham K, Ord T. Human TRB3 is upregulated in stressed cells by the induction of translationally efficient mRNA containing a truncated 5′-UTR. Gene 2009; 444: 24-32.
57. Du K, Herzig S, Kulkarni RN, Montminy M. TRB3: a tribbles homolog that inhibits Akt/PKB activation by insulin in liver. Science 2003; 300: 1574-1577.
58. Hu P, Han Z, Couvillon AD, Exton JH. Critical role of endogenous Akt/IAPs and MEK1/ERK pathways in counteracting endoplasmic reticulum stress-induced cell death. J Biol Chem 2004; 279: 49420-49429.
59. Jousse C, Deval C, Maurin AC etal. TRB3 inhibits the transcriptional activation of stress-regulated genes by a negative feedback on the atf4 pathway. J Biol Chem 2007; 282: 15851-15856.
60. Örd D, Meeritsa K, Örd T. TRB3 protects cells against the growth inhibitory and cytotoxic effect of ATF4. Exp Cell Res 2007; 313: 3556-3567.
61. Middleton E Jr, Kandaswami C, Theoharide TC. The effects of plant flavonoids on mammalian cells: implications for inflammation, heart Disease, and cancer. Pharmacol Rev 2000; 52: 673-751.
62. Williams RJ, Spencer JPE, Rice-Evans C. Flavonoids: antioxidants or signalling molecules? Free Radic Biol Med 2004; 36: 838-849.
63. Hou DX, Kumamoto T. Flavonoids as protein kinase inhibitors for cancer chemoprevention: direct binding and molecular modeling. Antioxid Redox Signal 2010; 13: 691-719.
64. Görlacha KP, Kietzmamn T. The endoplasmic reticulum: folding, calcium homeostasis, signaling, and redox control. Antioxid Redox Signal 2006; 8: 1391-1418.